http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0040229-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b56931d402414ac2924944ec413ee2e2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-417
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-417
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-35
filingDate 2000-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_faeed080cce468dc2208ff9fc08c0646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4044821f2dcd7b303b2187af12e4ad1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_601eed2266703208055a8ba3653c0f57
publicationDate 2001-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0040229-A3
titleOfInvention Synergistic tumorcidal response induced by histamine
abstract The present invention relates to methods of treating cancer in which histamine is administered in conjunction with other cancer therapies. The cancer therapy includes surgery, radiation, immunotherapy, the administration of an agent which enhances the humoral immune response of the patient or any combination thereof.
priorityDate 1999-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9605289-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9742968-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0282002-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9605231-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9324144-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9314754-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9104037-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9722357-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574898

Total number of triples: 39.